Company Analysis

PRF Technologies Ltd. (PRFX)

Nasdaq: PRFX · Pharmaceutical Preparations · Tel Aviv · filing with the SEC since 2020
Grade3.8
◀ Past 5.3● Present 3.0▶ Future 3.4
3 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

4 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to PRF Technologies Ltd.’s names, not what it holds today.

Patents granted
4
4 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
6
since 2001, to Dec 31, 2025
Names they are printed under
4
a former name, a subsidiary
By yearGrantedApplications published
'15'17'18'19'20'21'23
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
PAINREFORM LTD. a former name
IL, as the owner printed on each patent
3 granted
1 published
LayerBio, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
3 published
PAINREFORM LTD. a former name
named as the applicant on its applications, in IL
0 granted
2 published
LAYERBIO, INC. a subsidiary
US, as the owner printed on each patent
1 granted
0 published
Newest grantseach row opens the USPTO’s own copy
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Feb 9, 20232023/0042169OCULAR DEVICE DELIVERY METHODS AND SYSTEMSMedical technologyLayerBio, Inc.
Dec 31, 20202020/0405538OCULAR DEVICE DELIVERY METHODS AND SYSTEMSMedical technologyLayerBio, Inc. · patent 11,185,441 granted from it
Feb 22, 20182018/0049985DEPOT FORMULATIONS OF A LOCAL ANESTHETIC AND METHODS FOR PREPARATION THEREOFPharmaceuticalsPAINREFORM LTD. · patent 10,206,876 granted from it
Feb 2, 20172017/0028078SUSTAINED-RELEASE DRUG FORMULATIONS FOR GLAUCOMAPharmaceuticalsLayerBio, Inc.
May 28, 20152015/0148325Depot Formulations of a Hydrophobic Active Ingredient and Methods for Preparation ThereofPharmaceuticalsPAINREFORM LTD. · patent 9,849,088 granted from it
Apr 23, 20152015/0111923Depot Formulations of a Local Anesthetic and Methods for Preparation ThereofPharmaceuticalsPAINREFORM LTD. · patent 9,668,974 granted from it

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton PRFX · research, not advice